Literature DB >> 32031509

In Vitro Fertilization Technology and Child Health.

Michael von Wolff1, Thomas Haaf.   

Abstract

BACKGROUND: Just under 3% of children in Germany, and approximately 6% of children in some other countries, such as Denmark, are now being conceived with the aid of in vitro fertilization (IVF) technology. Alongside the increased risk of organ malformation, there is now evidence for functional abnormalities due to epigenetic modifications.
METHODS: This review is based on pertinent publications retrieved by a literature search on currently known associations of IVF therapy with malformations and functional abnormalities. The potential implications for the treatment of infertility are discussed.
RESULTS: The risk of congenital malformations is approximately one-third higher in children conceived with the aid of IVF technology than in other children; specifically, there is an odds ratio (OR) of 1.29 (95% confidence interval, [1.03; 1.60]) for cardiac malformations, and there is a relative risk (RR) of 1.35 ([1.12; 1.64]) for musculo- skeletal malformations and 1.58 ([1.28; 1.94]) for genitourinary malformations. The risks of preterm birth and low birth weight are, respectively, 1.7 and 1.5 times higher in IVF singleton pregnancies than in non-IVF pregnancies. Cardiovascular changes are the main type of functional disturbance. Some of the risks associated with IVF have decreased in recent years. An association has been revealed between cardiovascular abnormalities and epigenetic modifications; the causes are thought to include not only maternal and paternal factors, but also the IVF techniques that are used. A modification of IVF therapies might lower the risks, but might also lower the success rate.
CONCLUSION: For the well-being of the children to be conceived, IVF therapy should hat cannot be treated by any other means, as the precise causes of the risks of IVF to child health are unclear.

Entities:  

Mesh:

Year:  2020        PMID: 32031509      PMCID: PMC7026576          DOI: 10.3238/arztebl.2020.0023

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  39 in total

1.  Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies.

Authors:  Urs Scherrer; Stefano F Rimoldi; Emrush Rexhaj; Thomas Stuber; Hervé Duplain; Sophie Garcin; Stefano F de Marchi; Pascal Nicod; Marc Germond; Yves Allemann; Claudio Sartori
Journal:  Circulation       Date:  2012-03-20       Impact factor: 29.690

2.  Assisted Reproductive Techniques and Risk of Beckwith-Wiedemann Syndrome.

Authors:  Alessandro Mussa; Cristina Molinatto; Flavia Cerrato; Orazio Palumbo; Massimo Carella; Giuseppina Baldassarre; Diana Carli; Clementina Peris; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Pediatrics       Date:  2017-06-20       Impact factor: 7.124

3.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

4.  The Dutch famine and its long-term consequences for adult health.

Authors:  Tessa Roseboom; Susanne de Rooij; Rebecca Painter
Journal:  Early Hum Dev       Date:  2006-07-28       Impact factor: 2.079

Review 5.  A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously.

Authors:  Gabija Lazaraviciute; Miriam Kauser; Sohinee Bhattacharya; Paul Haggarty; Siladitya Bhattacharya
Journal:  Hum Reprod Update       Date:  2014-06-24       Impact factor: 15.610

Review 6.  Ovulation induction and epigenetic anomalies.

Authors:  Patricia Fauque
Journal:  Fertil Steril       Date:  2013-03-01       Impact factor: 7.329

Review 7.  Antagonistic pleiotropy and p53.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Mech Ageing Dev       Date:  2008-07-01       Impact factor: 5.432

8.  Trends in perinatal health after assisted reproduction: a Nordic study from the CoNARTaS group.

Authors:  A A Henningsen; M Gissler; R Skjaerven; C Bergh; A Tiitinen; L B Romundstad; U B Wennerholm; O Lidegaard; A Nyboe Andersen; J L Forman; A Pinborg
Journal:  Hum Reprod       Date:  2015-01-20       Impact factor: 6.918

9.  Imprinting methylation errors in ART.

Authors:  Hitoshi Hiura; Hiroaki Okae; Hatsune Chiba; Naoko Miyauchi; Fumi Sato; Akiko Sato; Takahiro Arima
Journal:  Reprod Med Biol       Date:  2014-06-19

10.  Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life.

Authors:  Harald Lehnen; Ulrich Zechner; Thomas Haaf
Journal:  Mol Hum Reprod       Date:  2013-03-20       Impact factor: 4.025

View more
  4 in total

1.  Families formed through assisted reproductive technology: Causes, experiences, and consequences in an international context.

Authors:  Anne-Kristin Kuhnt; Jasmin Passet-Wittig
Journal:  Reprod Biomed Soc Online       Date:  2022-01-21

2.  Polygenic risk score for embryo selection-not ready for prime time.

Authors:  Alex Polyakov; David J Amor; Julian Savulescu; Christopher Gyngell; Ektoras X Georgiou; Vanessa Ross; Yossi Mizrachi; Genia Rozen
Journal:  Hum Reprod       Date:  2022-09-30       Impact factor: 6.353

3.  Perinatal and neonatal outcomes of pregnancies after early rescue intracytoplasmic sperm injection in women with primary infertility compared with conventional intracytoplasmic sperm injection: a retrospective 6-year study.

Authors:  Feng Xiong; Qing Sun; Guangui Li; Zhihong Yao; Peilin Chen; Caiyun Wan; Huixian Zhong; Yong Zeng
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-12       Impact factor: 3.007

4.  Can Time-Lapse Incubation and Monitoring Be Beneficial to Assisted Reproduction Technology Outcomes? A Randomized Controlled Trial Using Day 3 Double Embryo Transfer.

Authors:  Yu-Han Guo; Yan Liu; Lin Qi; Wen-Yan Song; Hai-Xia Jin
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.